| Code | 58728 | ||||||||||
| MA number | 42/0160/07-S | ||||||||||
| Product Form: | sol inf 1x100 ml/200 mg (fľ.PE) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| MAH, country: | Fresenius Kabi s.r.o., Czechia | ||||||||||
| Therapeutic Class: | 42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 30.04.2007 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Ciprofloxacin Kabi sol inf_03.2025.pdf
|
| SPC: |
SPC_Ciprofloxacin Kabi sol inf_03.2025.pdf
|
| Safety feature | Yes |
| Data update: | 24.02.2020 |
